Fosanis

Prescription digital therapeutic for all cancer patients

Fosanis believes that the best treatment results can only be achieved by addressing medical and psychological needs of patients. Its Mika platform helps patients by providing personalized digital support from monitoring to personalized coaching.

The company is headquartered in Berlin, Germany.

View website

Why we invested in Fosanis

Each cancer patient should be treated in a holistic and personalized way, and the Fosanis DTx platform, Mika, is laser-focused on helping individual patients navigate their individual cancer journey. Digital therapeutics in cancer have enormous potential to help patients as a complement to medical intervention.

 

Are you also an entrepreneur seeking funding?

Discover how we can help you bring your ambition to life

Contact us

Press Releases

Press Releases